SAVA

Cassava Sciences (SAVA)

About Cassava Sciences (SAVA)

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

Details

Daily high

$2.80

Daily low

$2.75

Price at open

$2.76

52 Week High

$42.20

52 Week Low

$2.23

Market cap

134.3M

Dividend yield

0.00%

Volume

912

Avg. volume

1.6M

P/E ratio

-1.92

Cassava Sciences News